Abstract: Over 100,000 implants were placed in the UK in 2010. As the numbers of patients with implant-retained prostheses increases, operators are encountering an increasing number of biological implant complications, most commonly peri-implant mucositis and peri-implantitis. The effective management of these complications is crucial to maintain patients' oral health. In particular, in contrast to common periodontal infections, some peri-implant infections may benefit from surgical intervention as a first line approach. Clinical Relevance: This article reviews the literature on the treatment options for peri-implant mucositis and peri-implantitis and proposes a protocol for their treatment Dent Update 2013; 40: 472-480
Over the last two decades, the use of dental implants has become a common treatment option for the replacement of missing teeth. Industry predictions suggest that over 200,000 implants will be placed in the UK in 2013. With the increasing utilization of this treatment option, the frequency with which operators can expect to encounter biological complications increases. Periimplant disease is a collective term for (SUP) (Figure 1b) , loss of supporting bone, visible clinically on reflection of the soft tissue for surgical treatment (Figure 1c ) but usually evidenced radiographically ( Figure  1d ) and, infrequently, implant mobility is clinically detectable. 3 The extent of periimplant disease may be graded, grade 0, 1, 2 or 3 ( Table 1 ). A more recently described, possibly different disease, 'retrograde periimplantitis' is diagnosed as a symptomatic periapical lesion, which may demonstrate a draining sinus. Radiographically, a periapical radiolucency may be seen, with normal osseointegration of the coronal portion of the implant (Figure 2 ). This lesion often develops shortly after implant insertion and, in the majority of the cases, requires surgical treatment, the discussion of which is beyond the scope of this paper. 4 
Prevalence
In large studies, peri-implant mucositis has been shown to occur in 80% of subjects and in 50% of implant sites. 3 Prevalence rates for peri-implantitis of 28−56% of subjects and 12−43% of implant the inflammatory reactions of tissues surrounding implants, encompassing two main entities: peri-implant mucositis and peri-implantitis. Originally, up to 0.2 mm of bone loss around implants in the first year, then 0.1 mm per year subsequently, was deemed within acceptable limits. 1 However, as techniques improve, less bone loss is expected. 2 Bone loss exceeding acceptable limits threatens implant success and therefore requires intervention.
Diagnosis and classification
Peri-implant mucositis describes inflammation in the mucosa at an implant area with no signs of loss of supporting bone. 3 Diagnosis of peri-implant mucositis is usually by detection of bleeding on probing (BOP), though redness and swelling may also occur (Figure 1a) . Peri-implantitis, on the other hand, describes the presence of inflammation in the mucosa at an (osseointegrated) implant with loss of supporting bone after one year in function. Diagnosis of peri-implantitis is based on increased probing pocket depths (BOP), suppuration 
Aetiology
There are broadly three theories currently proposed to explain the aetiopathogenesis of peri-implantitis: 1. A pathogenic microbial plaque is a necessary, albeit insufficient, cause; 2. The disease is the result of micromovement of the implant; and 3. A compromise in the host healing and adaptation predisposes to peri-implantitis.
The microbial biofilm associated with peri-implant disease is mixed and variable, although generally dominated by Gram-negative anaerobic bacteria. Several studies have indicated that peri-implantitis may be associated with an increased proportion of P. gingivalis, T. denticola, F. nucleatum, and A. actinomycetemcomitans. However, other studies identify a diverse spectrum of bacteria, including indigenous oral commensals and bacteria associated with infections of implanted medical devices (eg S. aureus and S. epidermidis). Therefore, the microbes associated with all cases of peri-implantitis may not simply be identical to those in periodontal disease. 5 Although biofilm removal is associated with clinical improvement, this does not prove that the biofilm causes the diseases.
In addition to the microbiological theory for implant bone loss, there is also experimental evidence that excessive or adverse loading may cause advancing bone resorption. Clinically applicable evidence is, however, currently somewhat lacking. 6 A further postulated theory is that of 'the compromised healing/ adaptation theory' . 7 In this theory, implant anchorage is disturbed by poor surgical technique, killing cells needed for repair. Alternatively, a poor host bed response, or excessive strain due to implant misfit or prosthodontic errors, or disturbance of bone cells and their vascular supply, may create an environment predisposing to colonization with pathogenic biofilm, leading to peri-implantitis. The theory of a poor host response is perhaps reinforced by evidence that there are subtle differences in the host response and lesion development in periodontal disease and peri-implantitis. 8 
Treatment of peri-implant diseases
In spite of the confusion around the aetiology of bone loss around implants, and whether it is a primary or secondary infective process, it is universally accepted that the microbial biofilm plays a central role in the disease 9 and its disruption is required for successful treatment. Prior to commencing treatment, iatrogenic factors that may promote peri-implantitis or mucositis should be identified and, if possible, addressed; for example, excess cement, over-contoured restorations or poorly positioned implants.
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Treatment of peri-implant mucositis
Peri-implant mucositis is usually treated by non-surgical mechanical therapy, using carbon fibre (Figure 3a (Figure 3e, f) . Whether mechanical therapy alone is effective, or requires adjunctive anti-microbial therapy, has been extensively investigated. Human studies have employed non-surgical mechanical therapies with adjunctive abrasive carbonate air powder, or phosphoric acid gel, and demonstrate that peri-implant mucositis can be successfully treated mechanically, with or without these adjuncts. Similarly, there is limited evidence for the adjunctive use of chlorhexidine irrigation and home use mouthwash. However, these are routinely used in practice.
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Treatment of peri-implantitis
While non-surgical periodontal therapy is almost always the first line of treatment for periodontitis, regardless of severity. By contrast, Renvert et al 31, 32 conclude that non-surgical therapy alone is not effective in the treatment of peri- implantitis. Peri-implantits treatment is further complicated by the design and the surface of the implants. Turned (smoother) implant surfaces demonstrated a 20% reduction in risk of being affected by peri-implantitis over a 3-year period, compared with rougher surface implants. 15, 16 Moreover, implant geometry and different surface characteristics may also predispose to peri-implantitis. 17 The ultimate aim of treatment of periimplantitis, similar to that of periodontitis, is regeneration of bone around the fixture, termed re-osseointegration. This has been shown to occur. Again, however, the implant surface exerts an effect. Although smoother surfaces may be slightly less susceptible to peri-implantitis, if affected by bone loss, these surfaces are also less amenable to re-osseointegration (22% re-osseointegration after treatment at turned sites compared with 84% at rougher, SLA™ sites). Biofilm removal is essential to re-osseointegration and this presents a significant challenge to successful treatment, as removing biofilm from rough surface implants is more difficult than its removal from smooth surfaces. 18, 19 This is a complex situation, as even different rough surfaces show differences in their ability to re-osseointegrate in beagle dog studies. 20 Treatment options for peri-implant diseases are discussed below.
Non-surgical treatment of peri-implant disease
Similar to treatment of peri-implant mucositis, peri-implantitis treatment may be attempted by the use of hand instruments and/or ultrasonics. In addition, the use of Er:YAG lasers has been investigated. For non-surgical treatment of peri-implantits, some studies describe removal of superstructure to improve access. However, none of these methods has been found to be consistently effective in the treatment of peri-implantitis. 21, 22 Early re-assessment at 1−2 months post non-surgical treatment is recommended. 10 
Surgical treatment
There is sufficient evidence demonstrating that non-surgical treatment fails to eliminate or reduce
Surface decontamination and conditioning
Rough surface implants may promote osseointegration. 26 However, these surfaces complicate the removal of plaque biofilms, therefore adjuncts and alternatives to mechanical debridement have been investigated. Er:YAG laser 22,27 subgingival irrigation with chlorhexidine 28 or air-powder abrasive unit, with or without citric acid, are no more effective than gauze soaked alternately in chlorhexidine and saline. 29 
Adjunctive antimicrobial therapy
Used in conjunction with surgical access, adjunctive local or systemic antibiotics 11 may reduce BOP and probing depths. [30] [31] [32] [33] [34] [35] [36] For example, successful results have been achieved with the use of tetracycline 50 mg/mL slurry over the debrided implant surface, in conjunction with systemic amoxicillin and metronidazole, incorporated into a six-step protocol to disinfect the implant surface.
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Regenerative and resective
Numerous studies have been undertaken to investigate the effectiveness of various regenerative procedures. All the bacterial counts at sites with periimplantitis, and that non-surgical treatment alone may not be sufficient to treat periimplantitis effectively. 23 Overall, a recent review of 26 studies estimated that surgical treatment for peri-implantitis eliminated symptoms of peri-implantitis and arrested progression of bone loss over a 5-year period, in 58% of the sites treated. The basis of this surgical treatment is access flap, removal of granulation tissue and implant surface decontamination. 24 However, within this framework, there is a wide variety of different surgical approaches to the treatment of peri-implantitis, making analysis of the most successful difficult. The essence of treatment remains to debride the implant surface and the majority of non-surgical mechanical debridement techniques described above have found application in surgical debridement (Figure 4 a−d) . More recently, in addition to the titanium scalers described above, a rotating titanium bristle brush has been described for use when surgically debriding implants. 25 The options for surface decontamination, antimicrobials, resective vs regenerative and closed vs open healing are discussed in more detail. Periodontics regenerative procedures for treating periimplantitis remain somewhat unpredictable. However, the use of autogenous bone graft, with or without xenograft, with a resorbable membrane, appears to provide the best results for treatment of full or partial bony defects. 37−42 Romeo et al 43 concluded that implantoplasty, creating a smooth implant surface of the exposed threads, in conjunction with resective surgery of the bone defect, represents a reliable surgical procedure for arresting and controlling the peri-implant chronic infection, when compared with resective surgery only.
Submerged versus non-submerged healing
Schwarz et al 44 demonstrated that open flap debridement and submerged healing, in which the implant is fully covered by the gingival tissue and not exposed to the oral environment, was superior to open flap debridement and non-submerged healing. Although effective, submerged healing is not always an option when treating implants in aesthetic areas or implants that are required as bridge abutments.
On the basis of the studies discussed above, the surgical approach suggested by the authors is outlined in Table  2 .
There is limited data regarding patient-centred outcomes for treatment of peri-implantitis. Patients should be advised of the likely soft tissue recession following treatment for peri-implantitis, the potential need for further treatment and implications of treatment failure.
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Prevention of peri-implantitis
Pre-installation
All risk factors for periodontal diseases should be assessed and controlled as far as is possible. 10 Periodontal treatment should be completed and there should have been a sufficient period of supportive therapy in order to assume stability.
Post implant placement
A follow-up programme for early detection of peri-implant diseases should include:  Periodontal status, including OH and BOP and risk factors;  Peri-implant pocket depths (using stainless steel or plastic periodontal probes);  Radiographic findings (first at the year review appointment and thereafter, if there is a clinical indication).
Conclusions
This review aims to present evidence from the most recent studies and systematic reviews 24,45−47 of the various treatment options for peri-implant diseases.
In conclusion:  Preventive measures should be initiated prior to implant installation, in particular completion of active periodontal therapy aiming to eliminate residual pockets with BOP.  Post placement for every implant patient a preventive programme should be tailored to each individual patient's risks, with regular maintenance and close monitoring to detect early disease.  Following diagnosis of peri-implantitis, risk factors should be identified and, if possible, eliminated; for example, excess cement, poor OH, smoking and diabetes, prior to active treatment of peri-implant disease.  Non-surgical treatment alone is sufficient to treat peri-implant mucositis, but is often not sufficient for the treatment of periimplantitis.  The various adjuncts to surgical decontamination procedures seem similarly effective at removing the biofilm.  Regenerative procedures may result in bony infill; this is unpredictable.  Submerged healing yields better results than non-submerged healing. Further research regarding the long-term outcomes of the myriad proposed treatment options for periimplantitis would be useful to clinicians. Ultimately, further advances are required to achieve predictable outcomes.
